If someone in your family has been diagnosed with breast cancer — a mother, sister, aunt, grandmother, or even a male relative — it is natural to wonder what that means for your own risk. For many women, a family history of breast cancer brings a background level of anxiety that can be hard to shake without proper information and guidance.

The reassuring reality is that most women with a family history of breast cancer are not at dramatically elevated risk. The significance of a family history depends on a number of specific factors — and a formal assessment with a specialist can cut through the uncertainty and give you a clear, accurate picture of where you actually stand.

At Breast & Surgical Oncology at The Poche Centre, we assess family history as a routine and important part of our practice. Our specialist breast surgeons have extensive experience in breast cancer risk assessment, and we work closely with familial cancer services and clinical geneticists to ensure every patient receives appropriate guidance, screening, and — where relevant — access to genetic testing and risk-reduction options.

Does Family History Always Mean Higher Risk?

Not necessarily — and this is one of the most important things to understand. Cancer is common in the general population, and many families will have one or more members affected by breast cancer purely by statistical chance rather than because of an inherited predisposition.

The vast majority of breast cancers — around 95% — are sporadic, meaning they arise without a clearly identifiable inherited cause. Only around 5% of breast cancers are attributable to a high-risk inherited gene mutation.

A single relative with breast cancer diagnosed after the age of 50 does not, in most cases, place you at significantly elevated risk. What matters is the pattern of cancer in your family — the number of relatives affected, the ages at which they were diagnosed, whether ovarian cancer is also present, and how closely related those family members are to you.

This is why a formal family history assessment — rather than anxiety or assumption — is so valuable. Many patients who come to us concerned about their family history discover that their actual risk level is closer to average than they feared. Others are identified as genuinely elevated risk and can be offered a structured plan to manage that risk proactively. Either way, you leave the consultation with clarity.

What Makes a Family History Significant?

When assessing a family history of breast cancer, the features that carry the most weight are:

Number of relatives affected — one relative with breast cancer is common and may carry limited additional risk. Two or more relatives on the same side of the family — particularly if they are first-degree relatives (mother, sister, daughter) — is more significant.

Age at diagnosis — breast cancer diagnosed at a young age, particularly before 50, and especially before 40, is a stronger indicator of a possible inherited predisposition than cancer diagnosed later in life.

Both sides of the family — inherited gene mutations can be passed through either the maternal or paternal line. A family history on your father's side is just as relevant as one on your mother's side, even though men rarely develop breast cancer themselves.

Ovarian cancer in the family — the combination of breast and ovarian cancer in the same family — or in the same individual — is a particularly strong indicator of a possible BRCA1 or BRCA2 mutation.

Male breast cancer — breast cancer in a male relative is rare and, when it occurs, significantly raises the likelihood of an inherited mutation, particularly BRCA2.

Bilateral breast cancer — a family member diagnosed with cancer in both breasts is a meaningful signal.

Ashkenazi Jewish ancestry — BRCA1 and BRCA2 mutations occur at a higher frequency in people of Ashkenazi Jewish descent, making family history particularly relevant in this population.

Known gene mutation in the family — if a first- or second-degree relative has tested positive for a BRCA1, BRCA2, PALB2, or other high-risk gene mutation, this changes your assessment entirely and genetic testing and counselling should be pursued promptly.

Understanding Inherited Gene Mutations

For the approximately 5% of women in whom breast cancer has a significant hereditary component, the cancer develops because of an inherited fault in one of a number of genes involved in the regulation of cell growth and DNA repair.

BRCA1 and BRCA2 are the most well-known. Women who carry a pathogenic mutation in BRCA1 have a lifetime breast cancer risk of approximately 50–72%, and a significantly elevated risk of ovarian cancer. BRCA2 carriers have a lifetime breast cancer risk of approximately 45–69%, with a lower but still meaningful ovarian cancer risk, as well as elevated risks of other cancers including pancreatic and prostate cancer in men.

Importantly, these mutations are inherited in an autosomal dominant pattern — meaning that each child of a carrier has a 50% chance of inheriting the mutation, regardless of sex. This has implications for the broader family, not just the individual being assessed.

Other high-risk genes are increasingly recognised as clinically important. These include PALB2, CHEK2, ATM, CDH1, and PTEN, among others. Modern genetic testing panels assess multiple genes simultaneously, providing a more comprehensive picture of inherited risk than was possible with earlier single-gene testing.

It is also important to note that even in families with a strong history of breast cancer, a specific gene mutation is not always identified. The absence of a detectable mutation does not mean risk is average — some familial risk is attributable to combinations of lower-penetrance genetic variants and shared environmental factors that are not yet fully characterised.

Genetic Counselling and Testing

If your family history raises concern, the next appropriate step is usually a referral to a familial cancer service or clinical geneticist — specialists dedicated to assessing inherited cancer risk and guiding genetic testing decisions.

Genetic counselling involves a detailed, structured assessment of your family history, an explanation of what genetic testing can and cannot tell you, discussion of the emotional and practical implications of testing, and — where testing is recommended — the collection of a blood or saliva sample for laboratory analysis.

Genetic testing is not appropriate for everyone with a family history of breast cancer, and it is most informative when the person tested is the family member who has actually been diagnosed with cancer (the "index case"), if they are available and willing to be tested. If no affected family member is available for testing, you can still be tested, but the results are harder to interpret.

If you test positive for a mutation, you will receive comprehensive genetic counselling to discuss the implications, and a clear plan for screening, surveillance, and risk-reduction options. Your blood relatives can then be offered targeted testing for the specific mutation identified in your family.

If you test negative for a mutation that has been identified in your family, this is highly reassuring — your risk is likely to be close to average population risk. If no mutation has been identified in your family but testing is negative, interpretation is more complex and your specialist will advise accordingly.

The decision to pursue genetic testing is deeply personal. Some people find that knowing their status empowers them to take action. Others prefer not to know. There is no right or wrong answer — what matters is that the decision is fully informed and made at a pace that feels right for you.

What Happens at a Family History Consultation?

When you come to Breast & Surgical Oncology at The Poche Centre for a family history assessment, your specialist will:

Take a detailed family history — covering both sides of your family, the types of cancer diagnosed, the ages at diagnosis, and any known genetic testing results. It is helpful to gather as much information as possible before your appointment — names of relatives affected, their diagnoses and ages if known, and any prior genetic testing results in the family.

Assess your overall risk level — using established clinical risk tools and the full clinical picture, your surgeon will estimate your level of risk and how it compares to the general population. This is not a simple yes or no — risk exists on a spectrum, and the consultation will give you a clear and honest picture of where you sit.

Formulate a personalised action plan — depending on your risk level, this may include organising genetic testing or referral to a familial cancer service or geneticist for formal genetic counselling and testing; a personalised screening and surveillance plan (which may include earlier or more frequent mammography, breast MRI, or both); non-surgical risk reduction measures such as lifestyle modification or chemoprevention; and, where appropriate and desired, discussion of surgical risk reduction options including risk-reducing mastectomy and/or salpingo-oophorectomy.

Provide time and support for decision-making — if surgical risk reduction is being considered, we ensure there is no pressure and ample time to fully explore the options. This includes written information, the opportunity to view outcomes from previous patients, and the option to speak with patients who have been through the process. Risk-reducing surgery is a major and irreversible decision — we support every patient to take as much time as they need to reach the right choice for them.

By the end of your consultation, you will have moved from uncertainty to clarity — with a genuine understanding of your risk and a concrete plan tailored to your individual circumstances.

You Don't Have to Navigate This Alone

A family history of breast cancer can carry a significant emotional weight — particularly when you have watched a parent, sibling, or other loved one go through diagnosis and treatment. Our team understands this, and we approach every family history consultation with the sensitivity it deserves.

Knowledge is empowering, not frightening. Understanding your risk puts you in control of your health — and whatever your risk level turns out to be, there are always steps that can be taken to manage it effectively.